Patent Assignment
Reel/Frame 067043/0478
Merger and Change of Name
Recorded: 2024-04-09
Pages: 6
Assignee
LUNG THERAPEUTICS, LLC
3801 S. CAPITAL OF TEXAS HWY., SUITE 330, AUSTIN, TEXAS, 78704
Covered Properties
(2)
Dry Powder Formulation of Caveolin-1 Peptides and Methods of Use Thereof
Dry Powder Formulation of Caveolin-1 Peptides and Methods of Use Thereof
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2021
From: WILLIAMS, ROBERT O., III; WATTS, ALAN B.; ZHANG, YAJIE; SAHAKIJPIJARN, SAWITTREE
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 057929/0056 →
Assignment of Assignor's Interest
Oct 27, 2021
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057929/0128 →
Assignment of Assignor's Interest
Dec 5, 2024
From: SHETTY, SREERAMA
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 069498/0648 →
Assignment of Assignor's Interest
Feb 12, 2025
From: CHRISTENSEN, DALE; KOLENG, JOHN J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 070200/0296 →
Assignment of Assignor's Interest
Feb 12, 2025
From: WILLIAMS, ROBERT O., III; WATTS, ALAN B.; ZHANG, YAJIE; SAHAKIJPIJARN, SAWITTREE
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 070200/0363 →
Assignment of Assignor's Interest
Mar 3, 2025
From: LUNG THERAPEUTICS, LLC
To: REIN THERAPEUTICS, INC.
Reel/Frame 070380/0626 →